An ibuprofen a day could keep Parkinson’s disease away
February 16, 2010 by admin · Leave a Comment
Contact: Rachel Seroka
rseroka@aan.com
651-695-2738
American Academy of Neurology
ST. PAUL, Minn. New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson’s disease, according to a study released today that will be presented at the American Academy of Neurology’s 62nd Annual Meeting in Toronto April 10 to April 17, 2010.
Communication breakdown: what happens to nerve cells in Parkinson’s disease
February 8, 2010 by admin · Leave a Comment
Contact: Anita Kar
anita.kar@mcgill.ca
514-398-3376
McGill University
A new study from The Montreal Neurological Institute and Hospital The Neuro - at McGill University is the first to discover a molecular link between Parkinson’s disease and defects in the ability of nerve cells to communicate. The study, published in the prestigious journal Molecular Cell and selected as Editor’s Choice in the prominent journal Science, provides new insight into the mechanisms underlying Parkinson’s disease, and could lead to innovative new therapeutic strategies.
Industrial cleaner linked to increased risk of Parkinson’s disease
February 6, 2010 by admin · Leave a Comment
Contact: Rachel Seroka
rseroka@aan.com
651-695-2738
American Academy of Neurology
ST. PAUL, Minn. Workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at a significantly higher risk of developing Parkinson’s disease, according to a study released today that will be presented at the American Academy of Neurology’s 62nd Annual Meeting in Toronto April 10 to April 17, 2010.
Common heart medications may also protect against Parkinson’s disease, study finds
January 20, 2010 by admin · Leave a Comment
Contact: Mark Wheeler
mwheeler@mednet.ucla.edu
310-794-2265
University of California - Los Angeles
UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson’s disease.
Brain abnormalities in Parkinson’s patients develop before symptoms occur
January 19, 2010 by admin · Leave a Comment
Contact: Jamie Talan
jtalan@nshs.edu
516-562-1232
North Shore-Long Island Jewish (LIJ) Health System
Scientists who have identified brain networks damaged in Parkinson’s disease have new evidence that these systems become abnormal a few years before symptoms appear. And what’s more, parts of the network appear to respond in a last ditch attempt to rescue the brain.
Genetic risk factor identified for Parkinson’s disease
January 14, 2010 by admin · Leave a Comment
Contact: Sven Winkler
presse@helmholtz-muenchen.de
49-893-187-3946
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health Read more
Small molecules found to protect cells in multiple models of Parkinson’s disease
December 27, 2009 by admin · Leave a Comment
Contact: Nicole Giese
giese@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research
FINDINGS: Several structurally similar small molecules appear capable of protecting cells from alpha-synuclein toxicity, a hallmark of Parkinson’s disease.
Hope for new Parkinson’s disease treatment
December 9, 2009 by admin · Leave a Comment
Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-203-192-2165
BioMed Central
Following up on their previous work showing the rescue of dopamine neurons by chemicals that interact with the retinoid X receptor (RXR), researchers have now investigated the potential of these chemicals, known as RXR ligands, for the treatment of Parkinson’s disease. Writing in the open access journal BMC Neuroscience the scientists describe the use of two cellular models of Parkinsonian damage to explore the neuroprotective function of the two RXR ligands LG268 and XCT.
New therapy targets for amyloid disease
December 3, 2009 by admin · Leave a Comment
Contact: Clare Elsley
clare@campuspr.co.uk
44-113-258-9880
University of Leeds
A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer’s and Parkinson’s and may open up a potential new area for therapeutics.
Findings that should speed the development of drugs for Parkinson’s disease
November 18, 2009 by admin · Leave a Comment
Australian scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinsons Disease.
